# Assessment of 2012 Bioequivalence Standards for Warfarin

> **NCT02574754** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** warfarin

## Key facts

- **NCT ID:** NCT02574754
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02574754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02574754, "Assessment of 2012 Bioequivalence Standards for Warfarin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02574754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*